SHS Gesellschaft für Beteiligungsmanagement mbH

shstuebingen Current page: 21

31. January 2020 - SHS News

Digital therapy provider Selfapy receives EUR 6 million: Medtech investor SHS joins investor pool

Selfapy is Germany’s leading provider of online therapy for mental stress and is already cooperating with 16 health insurance funds SHS is expecting strong impulses for digital health companies from Germany’s new Digital Healthcare Act (DVG) Fifth investment of SHS’ fifth fund: Medical technology and life science investor SHS Gesellschaft für Beteiligungsmanagement of Tübingen, Germany, […]

Read more
30. January 2020 - Press Releases

Handelsblatt: “Psychotherapy app Selfapy receives six million euros from investors”

In January, the Handelsblatt reported on the current financing round of Selfapy, a psychotherapy start-up that wants to make better and faster psychotherapy treatment possible with its app. Selfapy offers online courses for the treatment of burnout, depression, anxiety and eating disorders. Selfapy hopes that the new German digital care law (DVG) will make their […]

Read more
15. December 2019 - Social Projects

For our 2020 annual project, we are supporting “Swimming for All Children” (German: Schwimmen für alle Kinder), an initiative organized by the Lokales Bündnis für Familie Tübingen e.V. support body.

“Swimming for All Children” is organized on a voluntary basis and was established in April 2015 in cooperation with Runder Tisch Kinderarmut (Round Table on Child Poverty) and Bündnis für Familie (Alliance for the Family) in Tübingen. A survey conducted by the German Life Saving Association found that 59% of children are not confident swimmers […]

Read more
26. November 2019 - SHS News

Establishing a new standard for the life science industry: SHS supports internationalization and further growth of Single Use Support

As a solution provider for the life science industry, Single Use Support (SUS) increases patient safety and minimizes the risk of contamination SUS customers include well-known companies from Europe, Asia and America SUS platform technology can become the industry standard for fluid logistics processes in the life science, biotech, pharmaceutical and medical device industries The […]

Read more
7. November 2019 - Portfolio News

University Hospital Regensburg and numares present results for detection of acute kidney transplant rejection based on a simple urine test

Early non-invasive detection of kidney rejection after transplantation was the central aim of a collaboration between Prof. Dr. Bernhard Banas, Chairman of Nephrology at the University Hospital Regensburg (UKR) and the medical diagnostics company, numares. The results of their joint clinical trial “UMBRELLA” were just published in EBioMedicine and will be presented right now at the American Society of Nephrology’s […]

Read more
First Previous
...
1920
21
2223
...
Next Last